Saud A. Sadiq, MD, and Christen Shoesmith, MD, FRCPC
Neurology® 2019;93:1-2. doi:10.1212/WNL.0000000000008613
Considered an expert in regenerative medicine, Tisch MS Research Center of New York's Director and Chief Research Scientist Dr. Saud A. Sadiq was invited to review the use of stem cells in amyotrophic lateral sclerosis (ALS).
Research performed at Massachusetts General Hospital Neurological Clinical Research Institute (NCRI) under the direction of James Berry, MD et al.
TO READ FULL REVIEW PLEASE EMAIL A REQUEST TO: plevin@tischms.org
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.